Journal profile · Medicine-Internal Medicine
Journal of Lipid and Atherosclerosis
ISSN 2287-2892 · eISSN 2288-2561 · The Korean Society of Lipid and Atherosclerosis · Korea, Republic of
Journal of Lipid and Atherosclerosis: diamond open access (no APC); no APC; median 87 days to acceptance (66 articles, last 24 months); 41 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Journal of Lipid and Atherosclerosis is published by The Korean Society of Lipid and Atherosclerosis. By OpenAlex counts of its recent articles, its largest topics are Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins and Cholesterol and Lipid Metabolism, together about 44.2% of its articles. Its main subfields are Surgery and Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Lipid and Atherosclerosis (JLA), an international and peer-reviewed journal, is the official publication of the Korean Society of Lipid and Atherosclerosis. Its abbreviated title is ‘J Lipid Atheroscler (JLA)’. The JLA is published three times a year (January 25, May 25, and September 25). Aims The JLA aims to advance knowledge in lipid metabolism and atherosclerosis while enhancing understanding of the prevention, management of risk factors, and treatment of cardiovascular diseases. Scope The JLA publishes high-quality basic, translational, and clinical research in lipid metabolism, atherosclerosis, and cardiovascular disease. Topics include lipid disorders, vascular diseases, metabolism, clinical nutrition, and cardiovascular health. The journal also features methodological rounds that provide educational fundamentals and practical insights for researchers. While rooted in the Asian scientific community as the official publication of the Korean Society of Lipid and Atherosclerosis, the JLA is an international journal that actively welcomes submissions from researchers worldwide, fostering global collaboration and advancing scientific knowledge across borders. ·
From the journal's Aims & Scope
Research area (LetPub): Medicine-Internal Medicine
Editor-in-chief Best Practice ResearchPublisher website
Editorial board by country: 2 in mainland China (about 3%); most named South Korea 34, Argentina 4, Brazil 3, Mainland China 2, United States 2 (63 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Lipoproteins and Cardiovascular HealthMedicine23.8%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine12.2%
- Cholesterol and Lipid MetabolismMedicine8.3%
- Atherosclerosis and Cardiovascular DiseasesImmunology and Microbiology6.5%
- Lipid metabolism and disordersMedicine6.4%
- Cardiovascular Health and Risk FactorsMedicine4.3%
- Acute Myocardial Infarction ResearchMedicine3.9%
- Coronary Interventions and DiagnosticsMedicine3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Cardiology and Cardiovascular Medicine | Q1 | 35/409 | 91st |
| Endocrinology, Diabetes and Metabolism | Q1 | 29/250 | 88th |
| Internal Medicine | Q1 | 25/179 | 86th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PMCPubMedPublisher website
Other: Google Scholar, Crossref, KoreaMed, KoreaMed Synapse, KoMCI
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 10.2LetPub ·
- SJR 2026-06
- 1.84LetPub ·
- SNIP 2026-06
- 2.23LetPub ·
- h-index
- 31OpenAlex ·
- i10-index
- 98OpenAlex ·
- 2-year mean citedness
- 4.05OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 481 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 41 | 41 | 863 |
| 2025 | 41 | 41 | 1,088 |
| 2024 | 32 | 32 | 853 |
| 2023 | 29 | 29 | 553 |
| 2022 | 27 | 27 | 466 |
| 2021 | 26 | 26 | 253 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
87 daysMedian, submission to acceptance · P25–P75 54 days – 105 days
- Acceptance to online
- median 58 days (66 articles)
- Submission to online
- median 153 days
- Sample
- 66 articles with submission and acceptance dates (70 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC | |
| LetPub | No APC | No | — | |
| Publisher website | Yes, amount not published | — | — |
Other charges and waivers (author guidelines)
- Other fees
- No other fees
- Page charges
- No page charges
- Submission fee
- No submission fee
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted7
- brief reportsThe JLA accepts and publishes original articles, review articles, brief reports, editorials, methodology rounds, and letters to editors.Length not stated
- editorialManuscripts are examined by the editorial board and re-evaluated by two or three expert reviewers assigned by the board. Another reviewer can be assigned if nee…Length not stated
- editorialsThe JLA accepts and publishes original articles, review articles, brief reports, editorials, methodology rounds, and letters to editors.Length not stated
- letters to editorsThe JLA accepts and publishes original articles, review articles, brief reports, editorials, methodology rounds, and letters to editors.Length not stated
- methodology roundsThe JLA accepts and publishes original articles, review articles, brief reports, editorials, methodology rounds, and letters to editors.Length not stated
- original articlesThe JLA accepts and publishes original articles, review articles, brief reports, editorials, methodology rounds, and letters to editors.Length not stated
- review articlesThe JLA accepts and publishes original articles, review articles, brief reports, editorials, methodology rounds, and letters to editors.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Peer review, Plagiarism, Preprints
- AI use Use of artificial intelligence (AI)-assisted technologies
JLA follows the recommendations of the International Committee of Medical Journal Editors (ICMJE) regarding the use of artificial intelligence (AI)-assisted technologies in scientific publishing. AI tools, including chatbots and other generative AI systems, must not be listed as authors or cited as authors. Authors remain fully responsible for the accuracy, integrity, originality, and final conten…
Source ↗Publisher website ·- Authorship Journal policies on authorship and contributorship
The ICMJE recommends that authorship be based on the following 4 criteria: 1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND 2) Drafting the work or revising it critically for important intellectual content; AND 3) Final approval of the version to be published; AND 4) Agreement to be accountable for all a…
Source ↗Publisher website ·- Conflicts of interest Journal policies on conflicts of interest/competing interests
Authors must disclose competing interests. Model summary
All authors must disclose any financial or non-financial competing interests that could influence, or be perceived to influence, the work reported in the manuscript. The corresponding author is responsible for submitting disclosure information for all authors at the time of submission. All sources of funding must be stated explicitly, and the role of any sponsor in study design, data collection, a…
Source ↗Publisher website ·- Data availability Journal policies on data sharing and reproducibility
Data Availability Statement required for original research. Model summary
JLA supports data sharing and transparency to improve the accuracy and reproducibility of published research. Original research articles should include a Data Availability Statement describing whether the raw data, analysis data, analytic code, or study materials are publicly available, available on reasonable request, or unavailable because of legal, ethical, or privacy restrictions. If data are …
Source ↗Publisher website ·- Publication ethics
COPE guidance for complaints and misconduct. Model summary
JLA follows relevant COPE guidance in handling complaints, appeals, and allegations of research or publication misconduct.
Source ↗Publisher website ·- License & copyright
Copyright transferred to Korean Society of Lipid and Atherosclerosis upon publication. Model summary
All published papers have become the permanent property of the Korean Society of Lipid and Atherosclerosis. Upon publication of the articles, all the copyrights are transferred to the Korean Society of Lipid and Atherosclerosis.
Source ↗Publisher website ·- Peer review Editorial and Peer Review Process
Double-blind peer review. Model summary
Manuscripts are examined by the editorial board and re-evaluated by two or three expert reviewers assigned by the board. Another reviewer can be assigned if needed. JLA uses double-blind review, which means that both the reviewer and author identities are concealed from the reviewers, and vice versa, throughout the review process. To facilitate this, authors need to ensure that their manuscripts a…
Source ↗Publisher website ·- Plagiarism Plagiarism and duplicate publication
Plagiarism is defined as the use of previously published material without appropriate attribution. Prior to peer review, all submitted manuscripts are screened for plagiarism by the Editor-in-Chief using iThenticate. If plagiarism or substantial textual overlap is identified at any stage before or after publication, JLA will take appropriate editorial action in accordance with the relevant guidanc…
Source ↗Publisher website ·- Preprints Preprint policy (Posted on March 2, 2023)
A preprint can be defined as a version of a scholarly paper that precedes formal peer review and publication in a peer-reviewed scholarly journal. JLA allows authors to submit a manuscript that have been posted on preprint platform to the journal. It is not treated as duplicate submission or duplicate publication. JLA recommend authors to disclose it with only single DOI during the submission proc…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- The Korean Society of Lipid and Atherosclerosis
- Country or region
- Korea, Republic of
- Language
- English, Korean
- ISSN
- 2287-2892
- Electronic ISSN
- 2288-2561
- Society / sponsor
- Korean Society of Lipid and Atherosclerosis
- Latest issue on the website
- Volume 15, Issue 2 (May 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Journal of Lipid and Atherosclerosis
How long does peer review take at Journal of Lipid and Atherosclerosis?
Based on the dates recorded on 66 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 87 days (interquartile range 54–105 days); authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Journal of Lipid and Atherosclerosis based?
Of the 63 board members whose country the journal's board page names, 2 (about 3%) are in mainland China; the countries named most often are South Korea (34), Argentina (4) and Brazil (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Lipid and Atherosclerosis?
According to LetPub and DOAJ records, Journal of Lipid and Atherosclerosis is indexed in Scopus and DOAJ. The journal's website also lists PMC and PubMed; that list has not been checked against each database.
Is Journal of Lipid and Atherosclerosis open access, and what is the APC?
Journal of Lipid and Atherosclerosis is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .